Hypophosphatasia – biochemical and clinical manifestations, molecular enetic principles
Authors:
Ilja Chandoga 1; Ján Futas 2; RNDr. Robert Petrovič, Ph.D. 2; Ján Chandoga 2
Authors place of work:
II. ortopedicko-traumatologická klinika LF UK a N, Bratislava
1; Ústav lekárskej biológie, genetiky a linickej genetiky LF UK a N, Bratislava
2
Published in the journal:
Čas. Lék. čes. 2011; 150: 541-545
Category:
Case Report
Summary
Hypophosphatasia is a rare hereditary metabolic disorder accompanying deficit of tissue nonspecific serum alkaline phosphatase. The incidence of overt forms is estimated about 1 : 100000 live births. In the prenatal manifestation the disease may cause severe damage to the foetus with intrauterine death. In hildren here is efect of mineralization ith ickets signs and the subsequent hypercalcaemia a ypercalciuria may lead to death. In adults the main manifestation is osteomalacia, skeletal eformities and ractures, arly rthritis. In evere orms the heredity is autosomal ecessive ype. In mild orms the heredity may e ominant r ecessive. In two case reports we present clinical ourse of he disease n wo dult isters, where diagnosis of hypophosphatasia was first time onfirmed n Slovak population using olecular enetic methods.
Key words:
hypophosphatasia, alkaline phosphatase, osteomalacia, amino acid changes – T83, E174K.
Zdroje
1. Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, et al. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill 2001.
2. Mornet E. Hypophosphatasia. http://www.OJRD.com/content/ 2/1/40
3. Mornet E, Taillandier A, Peyramaure S, Kaper F, Muller F, Brenner R, BussiŹre P, Freisinger P, Godard J, LeMerrer M, Oury JF, Plauchu H, Puddu R, Rival JM, Superti-Furga A, Touraine RL, Serre JL, Simon-Bouy B. Identification of fifteennovel mutations in the tissue-nonspecifical kalinephosphatase (TNSALP) gene in European patients with severe hypophosphatasia. Eur J HumGenet 1998; 6: 308–314.
4. Henthorn PS, Whyte MP. Missense mutations of the tissue-nonspecifical kalinephosphatase gene in hypophosphatasia. Clin Chem 1992; 38: 2501–2505.
5. Hérasse M, Spentchian M, Taillandier A, Mornet E. Evidence of a founder effect for the tissue-nonspecifical kalinephosphatase (TNSALP) gene E174K mutation in hypophosphatasia patients. Eur J Hum Genet 2002; 10: 666-668.
6. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Ménez A, LeDu MH. Structural evidence for a functional role of human tissue nonspecifical kalinephosphatase in bone mineralization. J BiolChem 2001; 276: 31171–31178.
7. Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-base destimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 2011; 75: 439–445.
8. Davies AM, Johnson K, Whitehouse RW. Imaging of the Hip & Bony Pelvis. Berlin, Heidelberg: Springer-Verlag 2006.
9. Castriota-Scanderbeg A, Dallapiccola B. Abnormal Skeletal Phenotypes: From Simple Signs to Complex Diagnoses. Berlin, Heidelberg: Springer-Verlag 2005.
10. Unger S, Mornet E, Mundlos S, Blaser S, Cole D. Severe cleidocranial dysplasia can mimic hypophosphatasia. Eur J Pediatr 2002; 161: 623–626.
11. Barvencik F, Gebauer M, Schinke T, Amling M. Saethre-Chotzen: Multiple Fractures in a Patient with Mutations of TWIST1 and TNSALP. Clin Orthop Relat Res 2008; 466: 990–996.
12. Maricic M. Osteomalacia. Curr Osteoporos Rep 2008; 6: 130–133.
13. Whyte MP, Mumm S, Deal C. Adult Hypophosphatasia Treated with Teriparatide. J Clin Endocrinol Metab 2007; 92: 1203–1208.
14. Whyte MP, Kurtzberg J, Mcalister WH, Mumm S, Podgornik MN, Coburn SP, Ryan RM, Miller CR, Gottesma GS, Smith AK, Douville J, Waters-Pick B, Armstrong RD, Martin PL. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 2003; 18: 624–636.
15. Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, Mcalister WH, Mumm S, Whyte MP. Infantile Hypophosphatasia: Transplantation Therapy Trial Using Bone Fragments and Cultured Osteoblasts. J Clin Endocrinol Metab 2007; 92: 2923–2930.
16. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millán JL. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002; 99: 9445–9449.
17. Millán JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, Gramatikov S, Terkeltaub R, Camacho NP, Mckee MD, Crine P, Whyte MP. Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 2008; 23: 777–778.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Biochemical mechanisms of action of antidepressants
- Hypophosphatasia – biochemical and clinical manifestations, molecular enetic principles
- Conflict of Interest: The World Medical Association Statement
- Post-traumatic panniculitis (decubitus ulcer?) of the breast – a clinical case